コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e transfected with miR-214-3p, decreased the angiogenic potential.
2 reatment significantly decreased endothelial angiogenic potential.
3 olic activity, cell survival, migration, and angiogenic potential.
4 lar matrix (ECM) remodeling and insufficient angiogenic potential.
5 rowth and exhibited high tubulogenic but low angiogenic potential.
6 vival, and vasoconstriction while decreasing angiogenic potential.
7 s with a high proliferative capacity and pro-angiogenic potential.
8 patients is through attenuation of platelet angiogenic potential.
9 ists to platelets decreased VEGF release and angiogenic potential.
10 emonstrated a similar impact on the platelet angiogenic potential.
11 ells (MCF-7 cells) and exhibited a decreased angiogenic potential.
12 n the presence of anticoagulants rescued the angiogenic potential.
13 ated patients had decreased VEGF release and angiogenic potential.
14 Human recombinant CAGE protein displayed angiogenic potential.
15 as the invasion, tumorigenic potential, and angiogenic potential.
16 own to regulate eosinophil viability and pro-angiogenic potential.
17 ogenic potential, and enhance their inherent angiogenic potential.
18 ent and -independent cell growth and reduced angiogenic potential.
19 ed SDF1-mediated in vitro cell migration and angiogenic potential.
20 cellular electrical resistance and increased angiogenic potential.
21 c agents have been developed which have anti-angiogenic potential.
22 cal for AdE4(+)-mediated survival of ECs and angiogenic potential.
23 ptosis and reduce both cellular invasion and angiogenic potential.
24 lost their ability to invade and had reduced angiogenic potential.
25 proliferation of HMEC-1, thus demonstrating angiogenic potential.
26 e of genetic factors that control individual angiogenic potential.
27 neonatal ventricular endocardial cells lack angiogenic potential and do not contribute to new corona
28 nt conditioned medium (CM) was evaluated for angiogenic potential and for expression of angiogenic fa
30 phenotypes from control cells with regard to angiogenic potential and rates of proliferation and apop
32 fic mTORC1 activation to decreased stemness, angiogenic potential, and disruption of p53 and Wnt path
33 herapeutic target and indicator of a tumor's angiogenic potential, and enables predictions that are s
34 st myogenic differentiation potency, highest angiogenic potential, and relatively high production of
35 es and NSCLC cells synergistically increases angiogenic potential, and that this is due to an increas
36 in cell-based therapies due to their robust angiogenic potential, are limited in their therapeutic c
37 tion, we demonstrate that A(2A) receptor has angiogenic potential, as assessed by increases in cell p
38 erminal 20 peptide (PAMP), exhibits a potent angiogenic potential at femtomolar concentrations, where
39 ydrogel and cell therapy generates a greater angiogenic potential at the ischemic site than cell ther
40 the vascular nodules resulted in the loss of angiogenic potential both in vitro and in vivo in the ch
41 l line that lacks osteogenic, adipogenic and angiogenic potential but is capable of differentiation t
42 with reduced tumor immunosuppression and neo-angiogenic potential by TAMs, MIF deficiency confers pro
43 -mobilized blood displayed increased in vivo angiogenic potential compared with AMD3100-mobilized CAC
44 s showed higher tumorigenic, metastatic, and angiogenic potential compared with parental PC-9 cells.
45 mice developed normally, but showed enhanced angiogenic potential compared with TbetaRII(endo+/+) mic
47 e conditions, while preserving their in vivo angiogenic potential for tubulogenesis and sprouting.
48 arrier formation (EV-miR-21) and rescued the angiogenic potential (HDL-miR-132) of ECs cultured in se
49 /NF90 isoform showed reduced tumorigenic and angiogenic potential in an orthotopic breast tumor model
51 e show that iMSCs retain partial support and angiogenic potential in MDS, coinciding with expanded BM
58 sulted in cytoskeletal remodeling, increased angiogenic potential, loss of cellular layer integrity a
59 antability of tumor stroma suggests that the angiogenic potential of a tumor xenograft, which determi
60 After angiogenesis blockade in vivo, the angiogenic potential of atherosclerotic tissue is suppre
62 e for AXL/S100A10 signaling in mediating the angiogenic potential of ccRCC cells and support the comb
63 role for GAS6/AXL signaling in promoting the angiogenic potential of ccRCC cells through the regulati
67 dE4+) selectively modulates the survival and angiogenic potential of ECs by as of yet unrecognized me
68 infection with AdE4(+) vectors increased the angiogenic potential of ECs by promoting EC migration an
69 beta 8 (ITGbeta8)-2 genes essential for the angiogenic potential of ECs-as targets of miR-143 and mi
71 ve shown that VEGF enhances the survival and angiogenic potential of endothelial cells by activating
72 expression and caused marked decrease in the angiogenic potential of endothelial cells without affect
75 via thermal oxidation method to enhance the angiogenic potential of human umbilical vein endothelial
76 ession of RPS15A in Huh7 cells increased the angiogenic potential of HUVEC in a paracrine fashion; co
77 24 plays an essential role in modulating the angiogenic potential of microvascular ECs by regulating
78 vailable living cellular sheets (LCS) on the angiogenic potential of neonatal dermal human microvascu
79 dental tissues, yet few studies focus on the angiogenic potential of PDLSC, none of which considered
80 Vascular size and irregularity reflect the angiogenic potential of prostate cancer and may serve as
81 of CNP and NPR-C, but not NPR-B, reduces the angiogenic potential of pulmonary microvascular endothel
82 lin significantly decreased the survival and angiogenic potential of radioresistant lung cancer cells
86 in due to aberrant bleeding could affect the angiogenic potential of the endometrium, creating a feed
87 cused on the role of ZNF24 in modulating the angiogenic potential of the endothelial compartment.
92 r, these studies highlight a key role of pro-angiogenic potential of transplanted osteogenic cells fo
94 es in KSHV-induced angiogenesis and that the angiogenic potential of vGPCR might also be due to its a
96 osteogenic progenitor cells with higher pro-angiogenic potential significantly enhance bone repair i
97 AKT (LY294002) and PKR (C16) disrupted their angiogenic potentials, suggesting that RNF213 and its up
98 elial cells that overexpress Bcl-2 have more angiogenic potential than control cells, and IL-8-neutra
100 sly implicated in sprout guidance, represses angiogenic potential to ensure the proper abundance and
101 itioned by MCT-1-negative cells restored its angiogenic potential to that of the MCF7-MCT-1 cells.
102 ese properties confer a significantly higher angiogenic potential to VEGF111 in comparison with the o
104 etinal endothelial cell barrier function and angiogenic potential via activation of oxidative stress.
107 l cell chemotactic activity (as a measure of angiogenic potential) was significantly increased in res